IMPACT OF MORBID OBESITY AND OBESITY PHENOTYPE ON OUTCOMES POST TRANSCATHETER AORTIC VALVE REPLACEMENT

McInerney, A.Tirado-Conte, G.Rodes-Cabau, J.Campelo-Parada, F.Soto, J. D. TafurBarbanti, M.Munoz-Garcia, E.Arif, M.Lopez, D.Toggweiler, S.Veiga, G.Pylko, A.Sevilla, T.Compagnone, M.Regueiro, A.Serra, V.Carnero, M.Oteo, J. F.Rivero, F.Barbosa Ribeiro, H.Guimaraes, L.Matta, A.Echavarria, N. GiraldoValvo, R.Moccetti, F.Munoz-Garcia, A. J.Lopez-Pais, J.Garcia del Blanco, B.Carter Campanha Borges, D.Gonzalo, N.Dumont, E.Criscione, E.Dabrowski, M.Alfonso, F.de la Torre Hernandez, J. M.Cheema, A. N.Amat-Santos, I.Saia, F.Escaned, J.Nombela-Franco, L.2025-01-072025-01-072020-10-011355-6037https://hdl.handle.net/10668/26895enIMPACT OF MORBID OBESITY AND OBESITY PHENOTYPE ON OUTCOMES POST TRANSCATHETER AORTIC VALVE REPLACEMENTconference outputopen access10.1136/heartjnl-2020-ICS.31468-201Xhttps://heart.bmj.com/content/heartjnl/106/Suppl_4/A2.1.full.pdf607135100004